Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-020-00179-7
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC